Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-26 @ 2:10 AM
Study NCT ID:
NCT03713905
Status:
COMPLETED
Last Update Posted:
2023-04-10
First Post:
2018-09-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
Sponsor:
Guangzhou Gloria Biosciences Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-25
First Submit QC Date:
None
Study First Post Date:
2018-10-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-07
Last Update Post Date:
2023-04-10
Last Update Post Date Type:
ACTUAL